Intercept Pharmaceuticals... (ICPT)
NASDAQ: ICPT
· Real-Time Price · USD
19.00
0.04 (0.21%)
At close: Nov 07, 2023, 10:00 PM
Intercept Pharmaceuticals Revenue Breakdown
| Period Ending | Dec 31, 2022 | Dec 31, 2018 |
|---|---|---|
| Product Revenue | 285.71M | 177.78M |
| Product Revenue Growth | +60.71% | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2021 |
|---|---|
| Non-Us Revenue | 102.72M |
| Non-Us Revenue Growth | n/a |
| United States Revenue | 260.75M |
| United States Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 45.44M | 53.35M | 57.66M | 55.42M | 43.27M | 39.98M | 50.01M | 60.59M | 53.34M | 57.66M | 59.27M | 69.96M | 70.62M | 93.36M | 98.56M | 93.68M | 76.83M | 69.68M | 77.23M | 70.97M | 56.81M | 65.22M | 62.47M | 84.33M | 61.36M | 66.92M | 61.08M | 74M | 44.38M | 42.27M | 90.43M | 44.89M | 24.74M | 20.97M | 13.14M |
| Selling, General, and Administrative Revenue Growth | -14.82% | -7.48% | +4.04% | +28.06% | +8.23% | -20.04% | -17.47% | +13.59% | -7.49% | -2.73% | -15.27% | -0.94% | -24.36% | -5.27% | +5.21% | +21.93% | +10.25% | -9.77% | +8.81% | +24.92% | -12.90% | +4.41% | -25.93% | +37.45% | -8.32% | +9.57% | -17.45% | +66.75% | +4.97% | -53.25% | +101.45% | +81.44% | +17.97% | +59.65% | n/a |
| Research and Development Revenue | 41.51M | 37.31M | 41.71M | 40.68M | 44.03M | 44.83M | 48.09M | 51.67M | 45.05M | 37.79M | 50.77M | 51.9M | 48.86M | 34.04M | 56.69M | 64.64M | 60.17M | 59.6M | 58.4M | 63.27M | 47.94M | 47.41M | 48.67M | 57.5M | 45.98M | 44.19M | 43.83M | 53.82M | 43.84M | 41.34M | 37.41M | 44.45M | 27.49M | 28.3M | 27.97M |
| Research and Development Revenue Growth | +11.28% | -10.56% | +2.53% | -7.61% | -1.77% | -6.79% | -6.92% | +14.69% | +19.20% | -25.56% | -2.18% | +6.22% | +43.52% | -39.95% | -12.30% | +7.43% | +0.95% | +2.06% | -7.71% | +31.98% | +1.11% | -2.58% | -15.35% | +25.06% | +4.04% | +0.82% | -18.56% | +22.77% | +6.04% | +10.50% | -15.82% | +61.69% | -2.86% | +1.18% | n/a |